AMANDA GODDARD: Open Payments
NPI 1245878107 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 17 payments from 12 companies in 2025. Trend: 2023 $578 · 2024 $1,597 · 2025 $444
Food & beverage: $379Education: $65
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $81 |
| Incyte Corporation | 1 | $65 |
| AstraZeneca Pharmaceuticals LP | 2 | $58 |
| PFIZER INC. | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Janssen Biotech, Inc. | 1 | $30 |
| Eisai Inc. | 1 | $27 |
| SERVIER PHARMACEUTICALS LLC | 1 | $25 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $19 |
Products named: CALQUENCE, INJECTAFER, KISQALI, TALVEY, Enhertu, Lenvima, PADCEV, Tibsovo.
Industry payments across MD — which companies pay providers there.
